Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05712395 · ClinicalTrials.gov registry record · NA
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
A NA study of Peripheral Artery Disease and Claudication, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05712395: Recruiting NA study of Peripheral Artery Disease and Claudication, sponsored by University of Oklahoma.
NCT05712395 is a NA study of Peripheral Artery Disease and Claudication that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 100 participants, below the 125-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05712395, a NA study of Peripheral Artery Disease and Claudication, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the Non-Ischemic Exercise (NICE) program to improve exercise and vascular outcome measures in patients with peripheral artery disease (PAD).
Primary Outcome
The change in peak walking time from the pre-test value to the post-test value (seconds)
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Oklahoma
- O'Donoghue Research Building, University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2029-07-31 |
| Phase | NA |
What NCT05712395 shows while recruiting
NCT05712395 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 125-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (20% lower).
The record links to 2 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT05712395 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05712395 about?
NCT05712395 is a clinical study titled "The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease". This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the Non-Ischemic Exercise (NICE) program to improve exercise and vascular outcome measures in patients with peripheral artery disease (PAD).
What is the current status of trial NCT05712395?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-09-09. Estimated completion is 2029-07-31.
What conditions does trial NCT05712395 study?
This clinical trial studies the following conditions: Peripheral Artery Disease, Claudication.
What interventions are being tested in trial NCT05712395?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05712395?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05712395 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05712395's enrollment target sits among peer trials
100 24th of 50 higher than 27 of 50 other Peripheral Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
-
Oxygen-guided Supervised Exercise Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI